vimarsana.com

WASHINGTON, Jan. 12, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. submitted a comment letter  on January 5, 2024, regarding the FDA's recently announced policy—by way of a draft guidance...

Related Keywords

Washington ,United States ,Kevin Moran ,Prnewswire Vanda Pharmaceuticals Inc ,Vanda Pharmaceuticals Inc ,Twitter ,Communications From Firms ,Unapproved Uses ,Cleared Medical Products ,Federal Food ,Cosmetic Act ,Vice President ,Chief Financial Officer ,Markets ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.